Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b.
BACKGROUND
Sarcoidosis is a multisystemic granulomatous disorder of unknown etiology that most commonly affects young adults. A probable induction of sarcoidosis by interferons (IFN) has been published. To this date, few cases of cutaneous sarcoidosis inpatients with chronic hepatitis C under interferon treatment have been reported.


OBJECTIVE
We describe a 50-year-old woman with chronic hepatitis C who developed lesions of cutaneous sarcoidosis three months after IFN treatment.


CONCLUSIONS
The possible role of INF therapy in the development of cutaneous sarcoidosis in a patient with chronic hepatitis C should be considered.
Neglia
V
V
Dermatology Department, Argerich County Hospital, University of Buenos Aires, Colon 660, Burzaco, Buenos Aires 1852, Argentina. aafernan@infovia.com.ar
Sookoian
S
S
Herrera
M
M
Abeldaño
A
A
Kien
M C
MC
Chouela
E
E
Frider
B
B
D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D012507:Sarcoidosis / Q000139:chemically induced* / Q000150:complications; D012871:Skin Diseases / Q000139:chemically induced* / Q000150:complications
D000998:Antiviral Agents; D016898:Interferon-alpha